Travoprost Clinical Trials

• Results of Mass Switch From Latanoprost to Travoprost
  ClinicalTrials.gov Identifier: NCT00347126 - Recruiting
  Glaucoma
  
• Bimatoprost 0.03% Versus Travoprost 0.004% in Patients Currently on Latanoprost 0.005%
  ClinicalTrials.gov Identifier: NCT00440011 - Recruiting
  Glaucoma; Ocular Hypertension
  
• IOP-Lowering Efficacy of Brinzolamide 1.0% Added to Travoprost 0.004%/Timolol 0.5% Fixed Combination as Adjunctive Therapy
  ClinicalTrials.gov Identifier: NCT00382226 - Recruiting
  Glaucoma
  
• Examining The Efficacy, Safety And Improved Tolerability Of Travoprost BAK Free Ophthalmic Solution (Travatan-Z) Compared To Prior Prostaglandin Therapy
  ClinicalTrials.gov Identifier: NCT00444665 - Recruiting
  Glaucoma
  
• A long-term safety study of once-daily Travatan
  ClinicalTrials.gov Identifier: NCT00051168 - Active, not recruiting
  Glaucoma, Open-Angle; Ocular Hypertension
  
• A Phase IV Study of Travoprost + Brinzolamide to Treat Glaucoma or Ocular Hypertension
  ClinicalTrials.gov Identifier: NCT00471380 - Recruiting
  Glaucoma; Ocular Hypertension
  
• IOP Lowering Efficacy of Travoprost/Brinzolamide Fixed Combination Ophthalmic Suspension in Patients With Open-Angle Glaucoma or Ocular Hypertension
  ClinicalTrials.gov Identifier: NCT00527501 - Recruiting
  Open-Angle Glaucoma; Ocular Hypertension
  
• A safety and efficacy study of Travoprost 0.004% compared to Latanoprost 0.005% in patients with open-angle glaucoma(OAG) or ocular hypertension(OHT)
  ClinicalTrials.gov Identifier: NCT00051142 - Completed
  Glaucoma, Open-Angle; Ocular Hypertension
  
• A Single Dose Comfort Comparison of Travoprost Bak Free 0.004% in One Eye Versus Latanoprost 0.005% in the Opposite Eye in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension
  ClinicalTrials.gov Identifier: NCT00527592 - Recruiting
  Open-Angle Glaucoma; Ocular Hypertension
  
• A safety and efficacy study of Travoprost 0.004% compared to Latanoprost 0.005% in patients with chronic angle-closure glaucoma
  ClinicalTrials.gov Identifier: NCT00051181 - Completed
  Glaucoma, Angle-Closure; Ocular Hypertension
  
• Phase IV study of TRAVATAN 0.004% in subjects with iris pigmentation changes
  ClinicalTrials.gov Identifier: NCT00047554 - Recruiting
  Open-Angle Glaucoma; Ocular Hypertension
  
• Effects of Travoprost on Neovascular Glaucoma
  ClinicalTrials.gov Identifier: NCT00441181 - Not yet recruiting
  Neovascular Glaucoma
  
• Diurnal Curves With Bimatoprost 0.03% Versus Travoprost 0.004%
  ClinicalTrials.gov Identifier: NCT00347802 - Completed
  Glaucoma
  
• 24-Hour IOP Control With TTFC vs Travoprost When Both Are Given PM in Subjects With POAG
  ClinicalTrials.gov Identifier: NCT00444184 - Completed
  Glaucoma
  
• 24-Hour IOP Control With Travoprost/Timolol Fixed Combination
  ClinicalTrials.gov Identifier: NCT00331240 - Completed
  Primary Open Angle Glaucoma; Exfoliation Syndrome
  
• Bimatoprost Monotherapy vs. Dual Therapy With Travoprost and Timolol in Patients With Glaucoma and Ocular Hypertension
  ClinicalTrials.gov Identifier: NCT00348023 - Completed
  Glaucoma
  
• Mechanism of Action of TRAVATAN 0.004% in Subjects with Glaucoma or Ocular Hypertension
  ClinicalTrials.gov Identifier: NCT00061503 - Completed
  Glaucoma; Ocular Hypertension
  
• Study of Brinzolamide and Timolol When Added to Travoprost in Primary Open-Angle Glaucoma or Ocular Hypertension
  ClinicalTrials.gov Identifier: NCT00372827 - Completed
  Primary Open-Angle Glaucoma; Ocular Hypertension; Pigment Dispersion Glaucoma
  
• A 6-week safety and efficacy study of Travatan compared to Xalcom in subjects with open-angle glaucoma(OAG) or ocular hypertension(OHT)
  ClinicalTrials.gov Identifier: NCT00051155 - Completed
  Glaucoma, Open-Angle; Ocular Hypertension